Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cap+Bev vs Cap+Iri+Bev 1st-line Therapy in mCRC

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified November 2010 by Ludwig-Maximilians - University of Munich.
Recruitment status was:  Recruiting
Sponsor:
Collaborator:
Roche Pharma AG
Information provided by:
Ludwig-Maximilians - University of Munich
ClinicalTrials.gov Identifier:
NCT01249638
First received: November 29, 2010
Last updated: March 11, 2011
Last verified: November 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):